Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP2925324 | Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia | RICHTER GEDEON NYRT. | Sep 29, 2021 |
EP3246021 | Apixaban Formulations | BRISTOL-MYERS SQUIBB HOLDINGS IRELAND | Aug 7, 2020 |
EP2684565 | Use Of Ulipristal Acetate For Treating Uterine Fibroids | LABORATOIRE HRA PHARMA | Jul 2, 2020 |
EP2805712 | Heat Sterilization Of Glucocorticoidsteriods | NORTON HEALTHCARE LIMITED | Nov 27, 2018 |
EP1687019 | Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices | NOVO NORDISK A/S | Aug 21, 2018 |
EP2793618 | Methods For Purifying Steviol Glycosides And Uses Of The Same | PURECIRCLE SDN BHD | Aug 9, 2018 |
EP2217214 | Pharmaceutical Formulation Comprising Ezetimibe | RATIOPHARM GMBH | Apr 19, 2018 |
EP3050556 | Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate | TEVA PHARMACEUTICAL INDUSTRIES, LTD. | Dec 21, 2017 |
EP2056832 | Compositions, Suitable For Oral Administration, Comprising A Triazolo [4, 5-D]Pyrimidin Derivate | ASTRAZENECA AB | Dec 18, 2017 |
EP2269603 | Treatment Of Solid Tumours With Rapamycin Derivatives | NOVARTIS AG | Feb 22, 2016 |
Feel free to send us a message here and we will get back to you